It’s only fair to share… Opakalim CAS 2376397-93-0 MF C18H22F2N4O MW 348.4 g/mol N-(1-tert-butyl-6-cyano-4,7-difluorobenzimidazol-2-yl)-3,3-dimethylbutanamide N-(1-tert-butyl-6-cyano-4,7-difluoro-1H-1,3-benzimidazol-2-yl)-3,3-dimethylbutanamidepotassium channel activator, antiepileptic, BHV-7000; BHV7 000, BPN-25203, BPN 25203, KB-3061, KB 3061, 73H9J7RBA2 BHV-7000 is under investigation in clinical trial NCT06419608 (Efficacy and Safety Study of BHV-7000 Monotherapy in Major Depression). Opakalim (also known as BHV-7000) is an investigational, small-molecule medication …